Trial Profile
A randomized, multiple-dose, parallel group, phase I trial of AXS-09 in healthy adult subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2018
Price :
$35
*
At a glance
- Drugs Dextromethorphan/esbupropion (Primary) ; Bupropion; Dextromethorphan
- Indications CNS disorders
- Focus Pharmacokinetics
- 05 Mar 2018 New trial record
- 26 Feb 2018 Primary endpoint (Change in dextromethorphan plasma concentrations from day 1 to day 8.) has been met, according to an Axsome Therapeutics media release.